BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

971 related articles for article (PubMed ID: 22696357)

  • 1. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.
    Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
    Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
    Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microwave coagulation for liver metastases.
    Storman D; Swierz MJ; Mitus JW; Pedziwiatr M; Liang N; Wolff R; Bala MM
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD010163. PubMed ID: 38534000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer.
    Mocellin S; Pasquali S; Nitti D
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007823. PubMed ID: 19588444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
    Meijerink MR; Puijk RS; van Tilborg AAJM; Henningsen KH; Fernandez LG; Neyt M; Heymans J; Frankema JS; de Jong KP; Richel DJ; Prevoo W; Vlayen J
    Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1189-1204. PubMed ID: 29666906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation.
    Loveman E; Jones J; Clegg AJ; Picot J; Colquitt JL; Mendes D; Breen DJ; Moore E; George S; Poston G; Cunningham D; Ruers T; Primrose J
    Health Technol Assess; 2014 Jan; 18(7):vii-viii, 1-283. PubMed ID: 24484609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
    Wade R; South E; Anwer S; Sharif-Hurst S; Harden M; Fulbright H; Hodgson R; Dias S; Simmonds M; Rowe I; Thornton P; Eastwood A
    Health Technol Assess; 2023 Dec; 27(29):1-172. PubMed ID: 38149643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases.
    Hof J; Wertenbroek MW; Peeters PM; Widder J; Sieders E; de Jong KP
    Br J Surg; 2016 Jul; 103(8):1055-62. PubMed ID: 27193207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.
    Riemsma RP; Bala MM; Wolff R; Kleijnen J
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009498. PubMed ID: 22972145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma.
    Liu B; Zhang Y; Chen H; Li W; Tsochatzis E
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013345. PubMed ID: 34981511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.
    Riemsma RP; Bala MM; Wolff R; Kleijnen J
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009498. PubMed ID: 23633373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
    Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
    Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave coagulation for liver metastases.
    Bala MM; Riemsma RP; Wolff R; Kleijnen J
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010163. PubMed ID: 24122576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WITHDRAWN: Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases.
    Al-asfoor A; Fedorowicz Z
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006039. PubMed ID: 17636822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency in the Management of Colorectal Liver Metastases: A 10-Year Experience at a Single Center.
    Aissou S; Cartier V; Hamy A; Plumereau F; Aube C; Lermite E
    Surg Technol Int; 2016 Oct; 29():99-105. PubMed ID: 27780345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.
    Wong SL; Mangu PB; Choti MA; Crocenzi TS; Dodd GD; Dorfman GS; Eng C; Fong Y; Giusti AF; Lu D; Marsland TA; Michelson R; Poston GJ; Schrag D; Seidenfeld J; Benson AB
    J Clin Oncol; 2010 Jan; 28(3):493-508. PubMed ID: 19841322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer.
    Scaife CL; Curley SA; Izzo F; Marra P; Delrio P; Daniele B; Cremona F; Gershenwald JE; Chase JL; Lozano RD; Patt YZ; Fornage BD; Vauthey JN; Woodall ML; Gonzalez KB; Ellis LM
    Ann Surg Oncol; 2003 May; 10(4):348-54. PubMed ID: 12734081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases.
    Al-Asfoor A; Fedorowicz Z; Lodge M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006039. PubMed ID: 18425932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer.
    Cirocchi R; Trastulli S; Abraha I; Vettoretto N; Boselli C; Montedori A; Parisi A; Noya G; Platell C
    Cochrane Database Syst Rev; 2012 Aug; (8):CD008997. PubMed ID: 22895981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.